In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: Recent investigations on the pharmacokinetics of levodopa (l-dopa) indicated that the presence of Helicobacter pylori in patients with Parkinson's disease, orally treated with l-dopa, influences the absorption of this compound, which consequently leads to decreased plasma levels. Therefore this work aims to study a potential in-vitro interaction of l-dopa with H. pylori and its surface adhesins. Methods: Solutions containing l-dopa of different concentrations were incubated with H. pylori at different bacterial densities and time intervals. Free l-dopa was quantified from the incubation supernatants by HPLC. A flow cytometric assay with fluorescence labelled H. pylori was used to investigate the influence of l-dopa on the bacterial adhesion of H. pylori: FITC-labelled bacteria were pre-incubated with l-dopa, followed by incubation with gastric epithelial cells (AGS cells) and FACS quantification of adhering bacteria. Key findings: Evaluation of time- and concentration-dependent incubation experiments indicated a significant decrease in l-dopa concentrations when coming into contact with H. pylori. The reduction in l-dopa concentrations was determined as 47 to 12%, referred to the initial starting concentration, with time-dependency and dependency of the H. pylori density. FITC-labelled H. pylori, pre-incubated with differing l-dopa concentrations, were shown to have a significantly reduced bacterial adhesion to AGS cells, with a maximum reduction of 22 ± 9%. These results demonstrate a direct interaction of l-dopa with the outer membrane proteins of H. pylori responsible for the adhesion to gastric epithelial cells. By this interaction the unbound l-dopa concentration in bacterial suspension was strongly reduced. Conclusions: This study suggests a potential in-vitro interaction of l-dopa with H. pylori adhesins, confirming the clinical changes found in pharmacokinetics of l-dopa therapy by H. pylori-positive patients with Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS
ROBINWARREN, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92719-8 · Cited by 3,597
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529 · cited 1×
“pylori, many of which are involved in bacterial adherence.([4]) Adhesins interact with either soluble molecules in the direct environment or with a variety of surface receptors and binding proteins of host cells.”
BackgroundHelicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
Research works printed but not linked: 24
- Blaser, 1999, Dynamics of Helicobacter pylori colonization in relation to the host response, Proc Natl Acad Sci USA, 96, 8359, 10.1073/pnas.96.15.8359 · doi:10.1073/pnas.96.15.8359
- Strömberg, 2003, Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum, FEMS, 36, 159
- Evans, 1993, Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori, J Bacteriol, 175, 674, 10.1128/jb.175.3.674-683.1993 · DOI · Paper page
- Simon, 1997, Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligo-saccharides, Infect Immun, 65, 750, 10.1128/iai.65.2.750-757.1997 · DOI · Paper page
- Boren, 1993, Attachment of H. pylori to human gastric epithelium mediated by blood group antigens, Science, 262, 1892, 10.1126/science.8018146 · DOI · Paper page
- Pietroiusti, 2008, Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders, Mini Rev Med Chem, 8, 135, 10.2174/138955708783498177 · DOI
- Pierantozzi, 2001, Helicobacter pylori induced reduction of acute levodopa absorption in Parkinson's disease patients, Ann Neurol, 50, 686, 10.1002/ana.1267 · DOI
- Pierantozzi, 2001, Reduced L-Dopa absorption and increased clinical fluctuations in Helicobacter pylori infected Parkinson's disease patients, Neurol Sci, 22, 89, 10.1007/s100720170061 · DOI
- Kurlan, 1988, Duodenal and gastric delivery of levodopa in parkinsonism, Ann Neurol, 23, 589, 10.1002/ana.410230611 · DOI · Paper page
- Hamlet, 1999, Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers, Gastroenterology, 116, 259, 10.1016/S0016-5085(99)70121-6 · DOI
- Calam, 1999, Helicobacter pylori modulation of gastric acid, Yale J Biol Med, 72, 195
- Drake, 1998, Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentration and effect of H. pylori eradication, Gut, 42, 768, 10.1136/gut.42.6.768 · DOI · Paper page
- Davies, 1994, Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo, Gut, 35, 179, 10.1136/gut.35.2.179 · DOI · Paper page
- Kankkunen, 2002, Improved stability and release control of levodopa and metaraminol using ionexchange fibers and transdermal iontophoresis, Eur J Pharm Sci, 16, 273, 10.1016/S0928-0987(02)00113-6 · DOI
- Lengsfeld, 2004, Glycosylated compounds from Okra inhibit adhesion of Helicobacter pylori to human gastric mucosa, J Agric Food Chem, 52, 1495, 10.1021/jf030666n · DOI · Paper page
- Lengsfeld, 2004, High molecular weight polysaccharides from black currant seed inhibit adhesion of Helicobacter pylori to human gastric mucosa, Planta Med, 70, 620, 10.1055/s-2004-827184 · doi:10.1055/s-2004-827184
- Wittschier, 2007, Large molecules as antiadhesive compounds against pathogens, J Pharm Pharmacol, 59, 777, 10.1211/jpp.59.6.0004 · DOI
- Icatlo Jnr, 1998, Affinity purification of Helicobacter pylori urease. relevance to gastric mucin adherence by urease protein, J Biol Chem, 273, 18230
- Evans, 2000, Helicobacter pylori adhesins: review and perspectives, Helicobacter, 5, 183, 10.1046/j.1523-5378.2000.00029.x · DOI
- Odenbreit, 2005, Adherence properties of Helicobacter pylori: impact on pathogenesis and adaptation to the host, Int J Med Microbiol, 295, 317, 10.1016/j.ijmm.2005.06.003 · DOI
- Lengsfeld, 2004, Isolierung und Charakterisierung bioaktiver Polysaccharide und Extrakte aus Okra (Abelmoschi esculenti fructus) und deren Einsatz in physiologischen Testsystemen mit Relevenz für den Gastrointestinaltrakt
- Mysore, 1999, Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound, Gastro-enterology, 117, 1316, 10.1016/S0016-5085(99)70282-9 · DOI · Paper page
- De Jonge, 2004, Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach, J Med Microbiol, 53, 375, 10.1099/jmm.0.45551-0 · DOI
- Krygowska-Wajs, 2009, Evaluation of gastric emptying in familial and sporadic Parkinson disease, Parkinson Relat Disord, 10.1016/j.parkreldis.2009.04.003 · DOI
Cited by
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521
The gut microbiome: an orchestrator of xenobiotic metabolism
Collins, S. L., & Patterson, A. D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.001 · Cited by 348
Beyond the stomach: An updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment
Testerman, T. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12781 · Cited by 336
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
Metadata
- Authors
- Niehues, M., & Hensel, A.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-01
- Volume
- 61
- Issue
- 10
- Pages
- 1303-1307
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2008664022
- Cited by
- 56
- References
- 3
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? https://app.cochat.ai/papers/10.1211/jpp.61.10.0005
- The paper
- Niehues, M., & Hensel, A. (2009). In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/jpp.61.10.0005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.